ProjectGAPVAC – Glioma Actively Personalized Vaccine Consortium / CIMT partner

Basic data

Acronym:

GAPVAC

Title:

Glioma Actively Personalized Vaccine Consortium / CIMT partner

Duration:

01/11/2012 to 01/11/2016

Abstract / short description:

The Glioma Actively Personalized VAccine Consortium (GAPVAC) is the first EU-funded initiative aimed at clinically developing biomarker-guided actively personalized vaccines (APVACs) to treat cancer patients.

Keywords:

Glioblastoma

immunotherapy

Immuntherapie

Peptide vaccine

Involved staff

Managers

Gouttefangeas, Cécile Sophie

Faculty of Medicine
University of Tübingen

Contact persons

Gouttefangeas, Cécile Sophie

Faculty of Medicine
University of Tübingen

Rammensee, Hans-Georg

Immunology
Interfaculty Institute for Cell Biology (IFIZ), Interfaculty Institutes

Local organizational units

Immunology

Interfaculty Institute for Cell Biology (IFIZ)
Interfaculty Institutes

Funders

Europäische Union (EU)

Brüssel, Belgium